Search Within

Victor Reuter

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (135)
  2. Journal Article (104)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (242)
  2. Human Oncology and Pathogenesis Program (242)
  3. GSK Faculty (209)
  4. Surgery (167)
  5. Department of Medicine (161)
  6. Solid Tumor Oncology Division (158)

More Groups

People
  1. Hikmat Al-Ahmadie (153)
  2. Yingbei Chen (128)
  3. Satish Tickoo (124)
  4. Anuradha Gopalan (123)
  5. Samson Fine (112)
  6. David Solit (97)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (4)
  4. 2022 (8)
  5. 2021 (12)
  6. 2020 (23)

More Years

Publications
  1. Laboratory Investigation (57)
  2. Modern Pathology (54)
  3. Journal of Clinical Oncology (26)
  4. Nature Communications (13)
  5. American Journal of Surgical Pathology (10)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. Nature Publishing Group (81)
  2. Nature Research (54)
  3. American Society of Clinical Oncology (30)
  4. American Association for Cancer Research (14)
  5. Elsevier Science, Inc. (13)
  6. Cell Press (10)

More Publishers

Results (242)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
    Journal Article

    Al-Ahmadie, H.; Iyer, G.; Hohl, M.; Asthana, S.; Inagaki, A.; Schultz, N.; Hanrahan, A. J.; Scott, S. N.; Brannon, A. R.; McDermott, G. C.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Copy number alteration burden predicts prostate cancer relapse
    Journal Article

    Hieronymus, H.; Schultz, N.; Gopalan, A.; Carver, B. S.; Chang, M.; Xiao, Y.; Heguy, A.; Huberman, K.; Bernstein, M.; Assel, M.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors
    Journal Article

    Feldman, D. R.; Iyer, G.; Van Alstine, L.; Patil, S.; Al-Ahmadie, H.; Reuter, V. E.; Bosl, G. J.; Chaganti, R. S.; Solit, D. B.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Sorbitol as a novel mechanism of hypoxia-inducible factor (HIF) pathway activation in clear cell papillary renal cell carcinoma (CCPRCC)
    Meeting Abstract

    Tickoo, S. K.; Hakimi, A. A.; Xu, J.; Lee, C. H.; Chen, Y. B.; Stirdivant, S.; Neri, B.; Wolfert, R.; Fine, S. W.; Al-Ahmadie, H.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • mTOR pathway activation characterizes a subset of unclassified renal cell carcinoma: Immunohistochemical, molecular and histologic analysis
    Meeting Abstract

    Kong, M. X.; Brannon, A. R. R.; Won, H.; Gandhi, A.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Russo, P.; Berger, M. F.; Tickoo, S. K.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: The utility of detecting aberrant succination by immunohistochemistry
    Meeting Abstract

    Chen, Y. B.; Brannon, A. R.; Dudas, M. E.; Won, H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Russo, P.; Berger, M. F.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Mano, R.; Ciriello, G.; Gonen, M.; Mikkilineni, N.; Sfakianos, J. P.; Kim, P. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • Integrated analysis of metastatic disease in clear cell renal cell carcinoma: A collaborative TCGA analysis
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mano, R.; Gonen, M.; Voss, M. H.; Reuter, V. E.; Rathmell, K.; Maranchie, J. K.; Appleman, L. J.; Tamboli, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry
    Journal Article

    Chen, Y. B.; Brannon, A. R.; Toubaji, A.; Dudas, M. E.; Won, H. H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Voss, M. H.; more...
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save